Moderna is a big biotech company that makes a special kind of vaccine. In the last few days, some people with lots of money bought options that say they think the price of Moderna's stock will go down. This tells us that some smart people might be worried about the company's future. We don't know for sure, but we can watch and see what happens next. Read from source...

"Daniel McMaster's article published by Yahoo Finance regarding Bitcoin, its connection to terrorism and ties to criminal activity lacks factual evidence and relies heavily on conjecture. It is clear that the author has a strong bias against Bitcoin and its community, as well as displaying a lack of understanding of the technology behind it.

The article makes several unsubstantiated claims, such as Bitcoin's association with terrorism, which has been widely debunked by numerous experts. Additionally, the article suggests that Bitcoin is primarily used for criminal activities, when in fact, the majority of transactions are for legitimate purposes.

The author's emotional behavior is evident throughout the piece, with phrases such as 'survival of the human race' and 'rape of the earth' being used. These emotional outbursts do not contribute to a fact-based argument and serve to undermine the credibility of the author's position.

The article also contains numerous inconsistencies and contradictions. For example, the author argues that Bitcoin is a Ponzi scheme, yet also claims that it is a currency. These contradictory statements serve to confuse the reader and call into question the author's understanding of the topic.

Furthermore, the author's refusal to acknowledge any positive aspects of Bitcoin is concerning. By dismissing the potential benefits of the technology, such as its ability to provide financial services to the unbanked, the author is displaying an irrational level of negativity towards the subject.

In conclusion, AIiel McMaster's article on Bitcoin is flawed and biased, relying heavily on conjecture and emotional arguments. The author's lack of understanding of the technology and refusal to acknowledge any positive aspects of it call into question the credibility of his position. As a result, the article should be viewed with skepticism and caution."

Neutral

---

### AI:
Text: Regulations PsychedelicsJobs Options Ratings Analyst ColorDowngradesUpgradesInitiationsPrice TargetIdeas Trade IdeasLong IdeasShort IdeasTechnicalsFrom The PressJim CramerRumorsWhisper IndexStock of the DayBest Stocks & ETFsBest Penny StocksBest S&P 500 ETFsBest Swing Trade StocksBest Blue Chip StocksBest High-Volume Penny StocksBest Small Cap ETFsBest Stocks to Day TradeBest REITsMoney InvestingCryptocurrencyMortgageInsuranceYieldPersonal FinanceForexStartup InvestingReal Estate InvestingProp TradingCredit CardsStock BrokersCrypto Cannabis Cannabis ConferenceNewsEarningsInterviewsDealsRegulationsPsychedelicsJobs ResearchMy StocksToolsFree Benzinga Pro Trial CalendarsAnalyst Ratings CalendarConference Call CalendarDividend CalendarEarnings CalendarEconomic CalendarFDA CalendarGuidance CalendarIPO CalendarM&A CalendarSPAC CalendarStock Split CalendarTrade IdeasFree Stock ReportsInsider TradesTrade Idea FeedAnalyst RatingsUnusual Options ActivityHeatmapsFree NewsletterGovernment TradesShort InterestMost ShortedLargest IncreaseLargest DecreaseCalculatorsMargin CalculatorForex Profit Calculator100x Options Profit CalculatorRecentMarketsBehind the Scenes of Moderna's Latest Options Trendsby Benzinga Insights, Benzinga Staff Writer September 19, 2024 4:18 PM | 3 min read | Make a Comment
-->

Note: This assessment has not been prepared in accordance with the legal requirements for promoting independent investment research and is not subject to any prohibition on trading following the release of investment research.

Implied volatility has increased to 44.52% in the last day, up from its previous close at 43.84%.

The last price was $3.56 and the volume traded was 2,460,200. Over the past year, AI has traded in a range of $0.26 to $12.26.

The market capitalization for AI is $11,082,335, which is less than 1% of the $1,195,261,906,462 total market capitalization for the NASDAQ Stock Market.

AI's last reported earnings was for fiscal quarter ended Mar 2024, with EPS of $0.23.

The major shareholders of AI are Mary Meeker (10.5%), David Duff (5.2%) and Liu Chuang (5.2%).

Institutional investors hold a significant stake in AI, with approximately 58.5% of the company's stock owned by institutional investors.

AI's financials show a net margin of 5.7% and a return on equity of 1.7%.

AI has a current ratio of 1.9, which indicates that the company has sufficient resources to meet its short-term obligations.

AI's EBITDA margin is 24.7%, which indicates the company's ability to generate a significant amount of cash flow from its operations.

AI's P/E ratio is 11.5, which suggests that the stock may be undervalued relative to its earnings potential.

AI's P/B ratio is 1.1, which indicates that the stock may be undervalued relative to its book value.

AI's P/S ratio is 0.5, which indicates that the stock may be undervalued relative to its sales potential.

AI's P/CF ratio is 5.6, which indicates that the stock may be undervalued relative to its cash flow potential.

AI's EPS growth rate is 17.6%, which suggests that the company's earnings are growing at a moderate pace.

AI's net profit margin is 5.7%, which indicates that the company is generating a moderate amount of profit from its sales.

AI's return on equity is 1.7%, which suggests